Molecular Profiling of Stage II and III Breast Cancer in Latin American Women Receiving Standard-of-Care Treatment
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Thomas G Gross, M.D.
National Cancer Institute (NCI)
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Instituto Leloir
Buenos Aires, Argentina
- Instituto Nacional de Cancer (inca)
Rio de Janeiro, Brazil
- Instituto Do C(sqrroot) Ncer Do Estado de S(sqrroot) O Paulo
São Paulo, Brazil
- Instituto de Salud Publica
Santiago, Chile
- Instituto Jalisciense de Cancerologia
Guadalajara, Mexico
- Universidad de Guadalajara
Guadalajara, Mexico
- Universidad de Sonora
Sonora, Mexico
- Institito Nacional de C(sqrroot)(degree)ncer
Montevideo, Uruguay
- Instituto Pasteur de Montevideo
Montevideo, Uruguay
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Dec 2014
- Primary completion
- 23 Dec 2014
- Completion
- 23 Sept 2020
- Last update posted
- 25 Sept 2020
- Registered enrollment
- 1,334
- Registry id
- NCT02326857
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.